Mitchell Dennis Vamos
10Patents
3h-index
14Co-inventors
49Inventor score
Filing activity: Nov 26, 2013 → Jul 29, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9546174B2 | Inhibitor of apoptosis protein (IAP) antagonists | Emerging Cross-Sectional Technologies | 8 | Active |
| US10047119B2 | Inhibitor of apoptosis protein (IAP) antagonists | Emerging Cross-Sectional Technologies | 4 | Active |
| US10544188B2 | Inhibitor of apoptosis protein (IAP) antagonists | Emerging Cross-Sectional Technologies | 3 | Active |
| US10266549B2 | ULK1 inhibitors and methods using same | Physics | 3 | Active |
| US10300074B2 | Use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapy | Human Necessities | 3 | Active |
| US11111270B2 | Inhibitor of apoptosis protein (IAP) antagonists | Emerging Cross-Sectional Technologies | 1 | Active |
| US10864217B2 | Use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapy | Human Necessities | 1 | Active |
| US10689397B2 | ULK1 inhibitors and methods using same | Physics | 0 | Active |
| US10774092B2 | ULK1 inhibitors and methods using same | Physics | 0 | Active |
| US11912786B2 | Inhibitor of apoptosis protein (IAP) antagonists | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.